295 related articles for article (PubMed ID: 25404362)
1. 4-1BB ligand signaling to T cells limits T cell activation.
Eun SY; Lee SW; Xu Y; Croft M
J Immunol; 2015 Jan; 194(1):134-41. PubMed ID: 25404362
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
3. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo.
Dawicki W; Watts TH
Eur J Immunol; 2004 Mar; 34(3):743-751. PubMed ID: 14991604
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
[TBL] [Abstract][Full Text] [Related]
6. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
7. Constitutive interaction between 4-1BB and 4-1BBL on murine LPS-activated bone marrow dendritic cells masks detection of 4-1BBL by TKS-1 but not 19H3 antibody.
Mbanwi AN; Lin GHY; Wang KC; Watts TH
J Immunol Methods; 2017 Nov; 450():81-89. PubMed ID: 28789924
[TBL] [Abstract][Full Text] [Related]
8. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand.
Gramaglia I; Cooper D; Miner KT; Kwon BS; Croft M
Eur J Immunol; 2000 Feb; 30(2):392-402. PubMed ID: 10671194
[TBL] [Abstract][Full Text] [Related]
9. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.
Pulle G; Vidric M; Watts TH
J Immunol; 2006 Mar; 176(5):2739-48. PubMed ID: 16493029
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.
Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H
J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172
[TBL] [Abstract][Full Text] [Related]
11. 4-1BB (CD137) ligand enhanced anti-tumor immune response against mouse forestomach carcinoma in vivo.
Li Q; Ai J; Song Z; Liu J; Shan B
Cell Mol Immunol; 2008 Oct; 5(5):379-84. PubMed ID: 18954562
[TBL] [Abstract][Full Text] [Related]
12. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
[TBL] [Abstract][Full Text] [Related]
13. A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.
Schoenbrunn A; Frentsch M; Kohler S; Keye J; Dooms H; Moewes B; Dong J; Loddenkemper C; Sieper J; Wu P; Romagnani C; Matzmohr N; Thiel A
J Immunol; 2012 Dec; 189(12):5985-94. PubMed ID: 23162126
[TBL] [Abstract][Full Text] [Related]
14. Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells.
Zhao Y; Croft M
Immunol Lett; 2012 Jan; 141(2):220-6. PubMed ID: 22037570
[TBL] [Abstract][Full Text] [Related]
15. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
[TBL] [Abstract][Full Text] [Related]
16. Comparison of induced versus natural regulatory T cells of the same TCR specificity for induction of tolerance to an environmental antigen.
Huang H; Ma Y; Dawicki W; Zhang X; Gordon JR
J Immunol; 2013 Aug; 191(3):1136-43. PubMed ID: 23817420
[TBL] [Abstract][Full Text] [Related]
17. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.
Lin GH; Sedgmen BJ; Moraes TJ; Snell LM; Topham DJ; Watts TH
J Immunol; 2009 Jan; 182(2):934-47. PubMed ID: 19124736
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.
Futagawa T; Akiba H; Kodama T; Takeda K; Hosoda Y; Yagita H; Okumura K
Int Immunol; 2002 Mar; 14(3):275-86. PubMed ID: 11867564
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
Macdonald DC; Hotblack A; Akbar S; Britton G; Collins MK; Rosenberg WC
J Immunol; 2014 Nov; 193(10):5056-64. PubMed ID: 25305314
[TBL] [Abstract][Full Text] [Related]
20. Extracellular domain of human 4-1BBL enhanced the function of cytotoxic T-lymphocyte induced by dendritic cell.
Wu C; Guo H; Wang Y; Gao Y; Zhu Z; Du Z
Cell Immunol; 2011; 271(1):118-23. PubMed ID: 21745658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
